106 related articles for article (PubMed ID: 28737056)
1. Quantification of human brain PDE4 occupancy by GSK356278: A [
van der Aart J; Salinas C; Dimber R; Pampols-Maso S; Weekes AA; Tonkyn J; Gray FA; Passchier J; Gunn RN; Rabiner EA
J Cereb Blood Flow Metab; 2018 Nov; 38(11):2033-2040. PubMed ID: 28737056
[TBL] [Abstract][Full Text] [Related]
2. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
[TBL] [Abstract][Full Text] [Related]
3. GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
Rutter AR; Poffe A; Cavallini P; Davis TG; Schneck J; Negri M; Vicentini E; Montanari D; Arban R; Gray FA; Davies CH; Wren PB
J Pharmacol Exp Ther; 2014 Jul; 350(1):153-63. PubMed ID: 24784567
[TBL] [Abstract][Full Text] [Related]
4. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
Thomas AJ; DaSilva JN; Lortie M; Renaud JM; Kenk M; Beanlands RS; deKemp RA
J Nucl Med; 2011 Feb; 52(2):263-9. PubMed ID: 21270457
[TBL] [Abstract][Full Text] [Related]
5. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
[TBL] [Abstract][Full Text] [Related]
6. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
[TBL] [Abstract][Full Text] [Related]
7. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
[TBL] [Abstract][Full Text] [Related]
8. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography.
DaSilva JN; Lourenco CM; Meyer JH; Hussey D; Potter WZ; Houle S
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1680-3. PubMed ID: 12458404
[TBL] [Abstract][Full Text] [Related]
9. [
Ooms M; Tsujikawa T; Lohith TG; Mabins SN; Zoghbi SS; Sumitomo A; Jaaro-Peled H; Kimura Y; Telu S; Pike VW; Tomoda T; Innis RB; Sawa A; Fujita M
J Cereb Blood Flow Metab; 2019 Jul; 39(7):1306-1313. PubMed ID: 29430995
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder.
Weidner LD; Wakabayashi Y; Stolz LA; Collins MT; Guthrie L; Victorino M; Chung J; Miller W; Zoghbi SS; Pike VW; Fujita M; Innis RB; Boyce AM
J Nucl Med; 2020 Nov; 61(11):1672-1677. PubMed ID: 32284396
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: a retest study and use of an image-derived input function.
Zanotti-Fregonara P; Zoghbi SS; Liow JS; Luong E; Boellaard R; Gladding RL; Pike VW; Innis RB; Fujita M
Neuroimage; 2011 Feb; 54(3):1903-9. PubMed ID: 21034834
[TBL] [Abstract][Full Text] [Related]
12. Identification and in vivo evaluation of a fluorine-18 rolipram analogue, [(18) F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain.
Thomae D; Morley TJ; Lee HS; Barret O; Constantinescu C; Papin C; Baldwin RM; Tamagnan GD; Alagille D
J Labelled Comp Radiopharm; 2016 May; 59(5):205-13. PubMed ID: 27006107
[TBL] [Abstract][Full Text] [Related]
13. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder.
Fujita M; Hines CS; Zoghbi SS; Mallinger AG; Dickstein LP; Liow JS; Zhang Y; Pike VW; Drevets WC; Innis RB; Zarate CA
Biol Psychiatry; 2012 Oct; 72(7):548-54. PubMed ID: 22677471
[TBL] [Abstract][Full Text] [Related]
15. Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET.
Fujita M; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Lu JQ; Liow JS; Seneca N; Tipre DN; Cropley VL; Imaizumi M; Gee AD; Seidel J; Green MV; Pike VW; Innis RB
Neuroimage; 2005 Jul; 26(4):1201-10. PubMed ID: 15961054
[TBL] [Abstract][Full Text] [Related]
16. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
[TBL] [Abstract][Full Text] [Related]
17. Characterization of r-[11C]rolipram for PET imaging of phosphodieterase-4: in vivo binding, metabolism, and dosimetry studies in rats.
Lourenco CM; Houle S; Wilson AA; DaSilva JN
Nucl Med Biol; 2001 May; 28(4):347-58. PubMed ID: 11395307
[TBL] [Abstract][Full Text] [Related]
18. Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET.
Lortie M; DaSilva JN; Kenk M; Thorn S; Davis D; Birnie D; Beanlands RS; deKemp RA
Mol Imaging Biol; 2012 Apr; 14(2):225-36. PubMed ID: 21424298
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.
Fujita M; Imaizumi M; D'Sa C; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Gee AD; Seidel J; Green MV; Pike VW; Duman RS; Innis RB
Synapse; 2007 Feb; 61(2):78-86. PubMed ID: 17117418
[TBL] [Abstract][Full Text] [Related]
20. Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
Niccolini F; Wilson H; Pagano G; Coello C; Mehta MA; Searle GE; Gunn RN; Rabiner EA; Foltynie T; Politis M
Neurology; 2017 Aug; 89(6):586-593. PubMed ID: 28701494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
